a drug for one cancer has succeeded at halting another completely in an admittedly small trial. but hey, when all 12 participants in the trial had their colo-rectal cancer go into remission after 6 months of treatment with dostarlimab, (with no adverse side-effects) it has to be a good sign! science marches on...